Trisomy 4 refers to the presence of additional chromosomal material from chromosome 4. Unlike trisomies 13, 18, or 21, which are well-documented, abnormalities of chromosome 4 are underrepresented in the medical literature. Their clinical expression varies significantly depending on the duplicated segment (short arm 4p or long arm 4q), the size of the excess fragment, and whether the anomaly is homogeneous or mosaic.
Segmental and mosaic trisomy 4: what CGH-array has changed
Complete trisomy 4, affecting the entire chromosome, is almost always lethal during embryonic development. Viable forms are almost always partial trisomies of chromosome 4, meaning duplications limited to a segment of 4p or 4q.
Read also : Everything you need to know about the hours for 0178918256 from Cdiscount to contact customer service
The standard G-banded karyotype detects large rearrangements, but since the adoption of CGH-array (chromosomal analysis on microarray), there has been a marked increase in diagnoses of microduplications on 4p and 4q. These anomalies, invisible on the classical karyotype, lead to phenotypes that are sometimes very mild, or even subclinical, which previously escaped identification.
To learn more about trisomy 4 and chromosome 4, it is important to distinguish these segmental forms from mosaic forms, where only a fraction of the cells carry the duplication. The mosaicism mitigates the severity of the clinical picture but complicates the prognosis: two patients with the same duplication may present radically different degrees of disability depending on the percentage of affected cells and the tissues involved.
Related reading : Everything You Need to Know About Online Tools to Succeed in Your Real Estate Project
Genotype-phenotype correlation on chromosome 4: short arm versus long arm
The location of the duplicated segment largely determines the clinical picture. This point remains poorly understood in public resources, which often conflate all abnormalities of chromosome 4 under a single description.
Duplications of the short arm 4p
4p duplications are characterized by their frequent impact on growth and neurological development. We regularly find in these cases a neonatal hypotonia associated with psychomotor developmental delay, feeding difficulties, and, in some patients, epilepsy. The facial dysmorphism may resemble that of Wolf-Hirschhorn syndrome (which results from a 4p deletion), sometimes leading to initial diagnostic confusion.
Duplications of the long arm 4q
4q duplications produce a different clinical spectrum. Congenital heart defects are more frequently reported, as well as renal or limb anomalies. Intellectual disability remains variable, ranging from mild impairment to moderate deficiency depending on the size and exact position of the duplicated fragment.
The phenotypic diversity among patients with cytogenetically similar duplications poses a major challenge for genetic counseling. Two comparable-sized 4q duplications can produce very different clinical pictures, making any individual prognosis uncertain in the absence of functional data on the involved genes.
Prenatal and postnatal diagnosis of partial trisomy of chromosome 4
In recent years, non-targeted chromosomal analysis programs in prenatal settings (CMA, prenatal exome) have detected these microduplications based on an isolated ultrasound finding: intrauterine growth retardation, small congenital heart defect, renal anomaly. The clinical picture is often not syndromic at the time of discovery, complicating parental decision-making.
The elements leading to diagnosis are as follows:
- An isolated ultrasound finding (growth retardation, heart or kidney malformation) followed by CMA or molecular karyotype on fetal sampling
- Postnatally, an association of psychomotor delay, hypotonia, and dysmorphic features prompting genetic analysis
- More rarely, an incidental finding during exome sequencing performed for another indication
The phenotypic variability and incomplete penetrance of these microduplications make prenatal genetic counseling particularly delicate. Reference centers for developmental anomalies report increasing difficulty in formulating a reliable prognosis in light of these findings, precisely because genotype-phenotype correlations remain insufficiently established for small segments.
Multidisciplinary management and preimplantation diagnosis
The management of a child with a partial trisomy of chromosome 4 does not fundamentally differ in structure from that of other rare chromosomal anomalies: neurological follow-up, psychomotor rehabilitation, speech therapy, cardiac and renal monitoring depending on the clinical picture. What changes is the almost total absence of published cohorts of sufficient size to guide therapeutic decisions.
The professionals involved cover a wide spectrum:
- Clinical geneticist for cytogenetic follow-up and family counseling
- Neuropediatrician for the management of epilepsy and developmental delay
- Pediatric cardiologist and nephrologist depending on the identified malformations
- Occupational therapist, psychomotor therapist, and speech therapist for daily functional support
Recent French recommendations on preimplantation diagnosis now include rare anomalies such as segmental trisomies for couples who have already had a child with a structural chromosomal anomaly. PGD, long reserved for trisomies 13, 18, 21, and sex chromosome anomalies, is gradually opening up to duplications and insertions involving chromosome 4, expanding reproductive options for these families.
The rarity of segmental trisomy 4 means that each new diagnosis contributes to an still fragmented knowledge base. Systematic sequencing in pediatrics reveals attenuated forms that redefine the spectrum of this anomaly, well beyond the severe picture historically described. For the families involved, the link with a reference center for developmental anomalies remains the most reliable resource for appropriate follow-up and updated genetic counseling.